Main navigation | Main content
Whether your business is pharmaceuticals, medical devices, transportation or food science, partnering in research through the University of Minnesota’s Minnesota Innovation Partnerships—or MN-IP—can significantly increase your company’s competitive edge and improve its bottom line.
Known nationally as the "Minnesota Method" for its groundbreaking approach to make it easier for business to work with the university research community, MN-IP is designed to improve access to university-developed technology while reducing the risk and cost associated with sponsoring research and licensing intellectual property (IP). MN-IP has two primary components: MN-IP Create and MN-IP Try and Buy.
For companies interested in creating new IP using sponsored research at the U of M.
MN-IP Create streamlines the process of sponsoring research and licensing IP. It establishes industry-friendly terms up front, granting companies an exclusive worldwide license to the resulting IP. Companies control all patent filings associated with the technology developed during the research project. And, they are free to sublicense the technology at any time.
For questions about MN-IP Create, contact Leza Besemann, technology strategy manager.
For companies interested in licensing existing U of M inventions
MN-IP Try and Buy provides companies with a low-cost, low-risk method to determine the commercial potential behind existing university-developed technologies. Companies can take available technologies for a low cost “test-run” (or even try them fee-free if qualified) to test the viability of the innovation for their company. The new program grants companies a low-cost agreement to analyze technology under pre-negotiated licensing terms for a trial period without incurring any U.S. patent costs until a patent issues and without paying royalties on the first $1 million in revenue. One of the program highlights is the discount allotted to Minnesota companies which reduces royalty rates and can eliminate fees for the trial period.
For questions about MN-IP Try and Buy, contact Rick Huebsch, associate director.
President & CEO, American Peat Technology
CEO & Chairman of the Board, International Cardio Corp.
U.S. Department of Commerce
CEO, Adama Materials, Inc.
Research Fellow, Industrial Operations, New Technologies, Bayer Material Science
Vice President RD&E, Technology Partnerships & Development, Ecolab
MN-IP featured in January 2014 issue of Technology Transfer Tactics